Active Ingredient History
Diphenhydramine (DPH) is an antihistamine and sedative mainly used to treat allergies, insomnia, and symptoms of the common cold. It is also less commonly used for tremors in parkinsonism, and nausea. It is taken by mouth, injected into a vein, injected into a muscle, or applied to the skin. Maximal effect is typically around two hours after a dose, and effects can last for up to seven hours. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Sleep Initiation and Maintenance Disorders (approved 2014)
Abdominal Pain (Phase 1)
Acute Pain (Phase 3)
Alcohol-Induced Disorders (Phase 1)
Alcoholism (Phase 2)
Alcohol-Related Disorders (Phase 1)
Alzheimer Disease (Phase 3)
Anemia, Sickle Cell (Phase 1)
Anesthesia (Phase 4)
Anxiety Disorders (Phase 3)
Arthritis, Rheumatoid (Phase 4)
Arthroplasty (Phase 4)
Asthma (Phase 4)
Autism Spectrum Disorder (Phase 2)
Autistic Disorder (Phase 2)
Bacterial Infections (Phase 4)
Blood Protein Disorders (Phase 2)
Brain Edema (Phase 2)
Breast Neoplasms (Phase 3)
Cannabis (Phase 3)
Carcinoma (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Cesarean Section (Phase 3)
Chronic Urticaria (Phase 3)
Cocaine-Related Disorders (Phase 2)
Colonoscopy (Phase 4)
Cough (Phase 4)
Crohn Disease (Phase 1/Phase 2)
Dementia (Phase 3)
Depression (Phase 3)
Depressive Disorder, Major (Phase 1)
Dermatitis, Atopic (Early Phase 1)
Diabetic Neuropathies (Phase 2)
Diphenhydramine (Phase 4)
Drug Delivery Systems (Phase 3)
Drugs, Investigational (Phase 1)
Eczema (Phase 3)
Emergency Service, Hospital (Phase 2)
Endometrial Neoplasms (Phase 3)
Esophageal Neoplasms (Phase 3)
Fabry Disease (Phase 4)
Gallbladder Diseases (Phase 1)
Gallstones (Phase 1)
Glycogen Storage Disease Type II (Phase 1)
Graft Rejection (Phase 2)
Graft vs Host Disease (Phase 2)
Headache (Phase 4)
Headache Disorders, Primary (Phase 2)
Head and Neck Neoplasms (Phase 3)
Healthy Volunteers (Phase 3)
Hematologic Diseases (Phase 2)
Hematopoietic Stem Cell Transplantation (Phase 2)
Hepatic Encephalopathy (Phase 2)
Hodgkin Disease (Phase 2)
Hyperthermia (Phase 4)
Hyperuricemia (Phase 1)
Hypnotics and Sedatives (Phase 4)
Hypotension, Orthostatic (Phase 1)
Immune System Diseases (Phase 2)
Immunoglobulin G4-Related Disease (Phase 2)
Inflammation (Phase 3)
Jaundice (Phase 1)
Kidney Diseases (Phase 3)
Kidney Failure, Chronic (Phase 2)
Kidney Neoplasms (Phase 2)
Kidney Transplantation (Phase 2)
Leukemia (Phase 2)
Leukemia, Hairy Cell (Phase 1)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, Myeloid, Chronic-Phase (Phase 1/Phase 2)
Liver Diseases (Phase 2)
Liver Failure, Acute (Phase 2)
Liver Transplantation (Phase 1/Phase 2)
Lung Neoplasms (Phase 3)
Lupus Erythematosus, Systemic (Phase 3)
Lupus Nephritis (Phase 3)
Lymphoma (Phase 2)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Large-Cell, Immunoblastic (Phase 2)
Lymphoma, Non-Hodgkin (Phase 3)
Mastocytosis, Cutaneous (Phase 2)
Mastocytosis, Systemic (Phase 1)
Melanoma (Phase 1)
Metabolism (Phase 1)
Migraine Disorders (Phase 4)
Multiple Myeloma (Phase 3)
Multiple Sclerosis (Phase 3)
Multiple Sclerosis, Chronic Progressive (Phase 3)
Myelodysplastic Syndromes (Phase 2)
Nasal Obstruction (Phase 4)
Nausea (Phase 4)
Nefopam (Phase 3)
Neoplasms (Phase 2)
Neoplasms by Histologic Type (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Neoplastic Cells, Circulating (Phase 2)
Otitis Media (Phase 3)
Ovarian Neoplasms (Phase 3)
Pain (Phase 3)
Pain Management (Phase 2)
Pain, Postoperative (Phase 3)
Pancreatic Neoplasms (Phase 2)
Pancreatitis (Phase 1)
Paraproteinemias (Phase 2)
Pharmacokinetics (Phase 4)
Pharmacology, Clinical (Phase 1)
Plasmacytoma (Phase 1)
Post-Traumatic Headache (Phase 3)
Prostatic Neoplasms (Phase 4)
Psychomotor Agitation (Phase 4)
Psychophysiologic Disorders (Phase 3)
Pure Autonomic Failure (Phase 1)
Purpura, Thrombocytopenic, Idiopathic (Phase 1)
Restless Legs Syndrome (Phase 2)
Rhinitis (Phase 3)
Rhinitis, Allergic (Phase 4)
Schizophrenia (Phase 3)
Signs and Symptoms (Phase 4)
Sleep (Phase 4)
Sleep Disorders, Intrinsic (Phase 4)
Spinal Stenosis (Phase 4)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Diseases (Phase 1)
Stomach Neoplasms (Phase 2)
Stomatitis (Phase 4)
Stomatitis, Aphthous (Phase 2)
Stroke (Phase 2)
Sweating (Phase 4)
Urticaria (Phase 3)
Uterine Cervical Neoplasms (Phase 3)
Vomiting (Phase 2)
Vulvodynia (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
